$NEPT recovery at breakout $2.05 Recent Trade
Post# of 63802
Posted On: 11/24/2014 7:37:14 AM
$NEPT recovery at breakout $2.05
Recent Trades
Website
40% Buy
Shares Outstanding5: 74.98M
Float: 53.05M
% Held by Insiders1: 15.22%
% Held by Institutions1: 1.50%
Shares Short (as of Oct 31, 2014)3: 2.94M
Short Ratio (as of Oct 31, 2014)3: 13.70
Short % of Float (as of Oct 31, 2014)3: 5.10%
Headlines
Friday, November 21, 2014
Jim Hamilton Appointed President & CEO of NeptuneGlobeNewswire
Tuesday, November 11, 2014
Acasti Receives NASDAQ Notification Regarding Minimum Bid RequirementsGlobeNewswire
Wednesday, November 5, 2014
Neptune Completes Plant Ramp-UpGlobeNewswire
Thursday, October 30, 2014
Neptune Receives TSX Approval for Normal Course Issuer BidGlobeNewswire
Tuesday, October 28, 2014
Activist George Haywood Reveals New Biotech Targetat TheStreet
Monday, October 20, 2014
Neptune and BlueOcean Sign Licensing AgreementGlobeNewswire
Acasti Announces Grant of Stock OptionsGlobeNewswire
Wednesday, October 15, 2014
Neptune Announces Normal Course Issuer BidGlobeNewswire
Tuesday, October 14, 2014
Acasti Announces Second Quarter ResultsGlobeNewswire
Neptune Announces Second Quarter ResultsGlobeNewswire
Wednesday, October 8, 2014
Neptune to Hold Conference Call to Discuss Second Quarter ResultsGlobeNewswire
Tuesday, September 30, 2014
Acasti Announces Positive Top-Line Pharmacokinetic ResultsGlobeNewswire
Monday, September 29, 2014
Acasti Reports Successful CaPre(R) Phase II TRIFECTA Results Proving Statistically Significant Improvements in Triglycerides & Non-HDL-CGlobeNewswire
Tuesday, September 23, 2014
Neptune Reaches Annualized Production Capacity of 100 Metric TonsGlobeNewswire
Tuesday, September 16, 2014
Short-term bulls diving for NeptuneoptionMONSTER
Wednesday, September 3, 2014
Neptune to Present at Rodman & Renshaw Global Investment ConferenceGlobeNewswire
Wednesday, July 30, 2014
Why Neptune Technologies (NEPT) Could Be Positioned for a SlumpZacks
Monday, June 9, 2014
Has Enzymotec Been Over-Punished?at Seeking Alpha
Friday, June 6, 2014
NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. FinancialsEDGAR Online Financials
Friday, May 30, 2014
Neptune, Acasti and NeuroBioPharm Announce Litigation Regarding its Former Chief Executive OfficerMarketwired
Recent Trades
Website
40% Buy
Shares Outstanding5: 74.98M
Float: 53.05M
% Held by Insiders1: 15.22%
% Held by Institutions1: 1.50%
Shares Short (as of Oct 31, 2014)3: 2.94M
Short Ratio (as of Oct 31, 2014)3: 13.70
Short % of Float (as of Oct 31, 2014)3: 5.10%
Headlines
Friday, November 21, 2014
Jim Hamilton Appointed President & CEO of NeptuneGlobeNewswire
Tuesday, November 11, 2014
Acasti Receives NASDAQ Notification Regarding Minimum Bid RequirementsGlobeNewswire
Wednesday, November 5, 2014
Neptune Completes Plant Ramp-UpGlobeNewswire
Thursday, October 30, 2014
Neptune Receives TSX Approval for Normal Course Issuer BidGlobeNewswire
Tuesday, October 28, 2014
Activist George Haywood Reveals New Biotech Targetat TheStreet
Monday, October 20, 2014
Neptune and BlueOcean Sign Licensing AgreementGlobeNewswire
Acasti Announces Grant of Stock OptionsGlobeNewswire
Wednesday, October 15, 2014
Neptune Announces Normal Course Issuer BidGlobeNewswire
Tuesday, October 14, 2014
Acasti Announces Second Quarter ResultsGlobeNewswire
Neptune Announces Second Quarter ResultsGlobeNewswire
Wednesday, October 8, 2014
Neptune to Hold Conference Call to Discuss Second Quarter ResultsGlobeNewswire
Tuesday, September 30, 2014
Acasti Announces Positive Top-Line Pharmacokinetic ResultsGlobeNewswire
Monday, September 29, 2014
Acasti Reports Successful CaPre(R) Phase II TRIFECTA Results Proving Statistically Significant Improvements in Triglycerides & Non-HDL-CGlobeNewswire
Tuesday, September 23, 2014
Neptune Reaches Annualized Production Capacity of 100 Metric TonsGlobeNewswire
Tuesday, September 16, 2014
Short-term bulls diving for NeptuneoptionMONSTER
Wednesday, September 3, 2014
Neptune to Present at Rodman & Renshaw Global Investment ConferenceGlobeNewswire
Wednesday, July 30, 2014
Why Neptune Technologies (NEPT) Could Be Positioned for a SlumpZacks
Monday, June 9, 2014
Has Enzymotec Been Over-Punished?at Seeking Alpha
Friday, June 6, 2014
NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. FinancialsEDGAR Online Financials
Friday, May 30, 2014
Neptune, Acasti and NeuroBioPharm Announce Litigation Regarding its Former Chief Executive OfficerMarketwired
(0)
(0)Scroll down for more posts ▼